Skip to main content
Erschienen in: Gastric Cancer 1/2012

01.01.2012 | Original article

Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in gastric carcinoma surgery

verfasst von: Yoshio Haga, Yasuo Wada, Hitoshi Takeuchi, Koji Ikejiri, Masakazu Ikenaga, Osamu Kimura

Erschienen in: Gastric Cancer | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

We recently modified our prediction scoring system “Estimation of Physiologic Ability and Surgical Stress” and have designated the current version mE-PASS. This scoring system has been designed to obtain predicted postoperative mortality rates before surgery and this study was performed to assess its usefulness in elective surgery for gastric carcinoma.

Methods

We investigated seven variables for mE-PASS and evaluated the postoperative course in 3,449 patients who underwent elective surgery for gastric carcinoma in Japan between August 20, 1987 and April 9, 2007, in order to quantify the predicted in-hospital mortality rates (R). The calibration and discrimination power of R were assessed using the Hosmer–Lemeshow test and the area under the receiver operating characteristic curve (AUC), respectively. The ratios of observed-to-estimated mortality rates (OE ratios) were quantified as a measure of quality.

Results

The overall postoperative morbidity and mortality rates were 19.0 and 2.0%, respectively. R demonstrated good power in calibration (χ2 value, 12.5; df 8; P = 0.89) as well as discrimination (AUC, 95% confidence intervals: 0.80, 0.75–0.85). The OE ratios between hospitals ranged from 0.44 to 1.8. Overall, the OE ratios seemed to improve with time (OE ratio, 95% confidence intervals: 1.3, 0.73–2.4 for the early period between 1987 and 2000; 1.0, 0.59–1.7 for the middle period between 2001 and 2004; and 0.65, 0.36–1.2 for the late period between 2005 and 2007).

Conclusion

Based on these findings, mE-PASS might be useful for medical decision-making and for assessing the quality of care in elective surgery for gastric carcinoma.
Literatur
1.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.PubMedCrossRef Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.PubMedCrossRef
2.
Zurück zum Zitat Kajitani T. The general rules for the gastric cancer study in surgery and pathology: part 1—clinical classification. Jpn J Surg. 1981;11:127–39.PubMedCrossRef Kajitani T. The general rules for the gastric cancer study in surgery and pathology: part 1—clinical classification. Jpn J Surg. 1981;11:127–39.PubMedCrossRef
3.
Zurück zum Zitat Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.PubMedCrossRef Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.PubMedCrossRef
4.
Zurück zum Zitat Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745–8.PubMedCrossRef Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745–8.PubMedCrossRef
5.
Zurück zum Zitat Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996;347:995–9.PubMedCrossRef Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996;347:995–9.PubMedCrossRef
6.
Zurück zum Zitat Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg. 1996;83:1595–9.PubMedCrossRef Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg. 1996;83:1595–9.PubMedCrossRef
7.
Zurück zum Zitat Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303–8.PubMedCrossRef Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303–8.PubMedCrossRef
8.
Zurück zum Zitat Lamb P, Sivashanmugam T, White M, Irving M, Wayman J, Raimes S. Gastric cancer surgery—a balance of risk and radicality. Ann R Coll Surg Engl. 2008;90:235–42.PubMedCrossRef Lamb P, Sivashanmugam T, White M, Irving M, Wayman J, Raimes S. Gastric cancer surgery—a balance of risk and radicality. Ann R Coll Surg Engl. 2008;90:235–42.PubMedCrossRef
9.
Zurück zum Zitat Degiuli M, Sasako M, Ponti A, Italian Gastric Cancer Study Group, et al. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97:643–9.PubMedCrossRef Degiuli M, Sasako M, Ponti A, Italian Gastric Cancer Study Group, et al. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97:643–9.PubMedCrossRef
10.
Zurück zum Zitat Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, et al. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70–3.PubMedCrossRef Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, et al. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70–3.PubMedCrossRef
11.
Zurück zum Zitat Zilberstein B, da Costa Martins B, Jacob CE, Bresciani C, Lopasso FP, de Cleva R, et al. Complications of gastrectomy with lymphadenectomy in gastric cancer. Gastric Cancer. 2004;7:254–9.PubMedCrossRef Zilberstein B, da Costa Martins B, Jacob CE, Bresciani C, Lopasso FP, de Cleva R, et al. Complications of gastrectomy with lymphadenectomy in gastric cancer. Gastric Cancer. 2004;7:254–9.PubMedCrossRef
12.
Zurück zum Zitat Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, et al. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg. 2006;23:192–7.PubMedCrossRef Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, et al. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg. 2006;23:192–7.PubMedCrossRef
13.
Zurück zum Zitat Portanova M, Vargas F, Lombardi E, Mena V, Carbajal R, Palacios N, et al. Results of specialization in the surgical treatment of gastric cancer in Peru. Gastric Cancer. 2007;10:92–7.PubMedCrossRef Portanova M, Vargas F, Lombardi E, Mena V, Carbajal R, Palacios N, et al. Results of specialization in the surgical treatment of gastric cancer in Peru. Gastric Cancer. 2007;10:92–7.PubMedCrossRef
14.
Zurück zum Zitat Haga Y, Ikei S, Ogawa M. Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following GI surgery. Surg Today. 1999;29:219–25.PubMedCrossRef Haga Y, Ikei S, Ogawa M. Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following GI surgery. Surg Today. 1999;29:219–25.PubMedCrossRef
15.
Zurück zum Zitat Haga Y, Ikei S, Wada Y, Takeuchi H, Sameshima H, Kimura O, et al. Evaluation of an Estimation of Physiologic Ability and Surgical Stress (E-PASS) scoring system to predict postoperative risk: a multicenter prospective study. Surg Today. 2001;31:569–74.PubMedCrossRef Haga Y, Ikei S, Wada Y, Takeuchi H, Sameshima H, Kimura O, et al. Evaluation of an Estimation of Physiologic Ability and Surgical Stress (E-PASS) scoring system to predict postoperative risk: a multicenter prospective study. Surg Today. 2001;31:569–74.PubMedCrossRef
16.
Zurück zum Zitat Haga Y, Wada Y, Takeuchi H, Sameshima H, Kimura O, Furuya T. Estimation of surgical costs using a prediction scoring system estimation of physiologic ability and surgical stress. Arch Surg. 2002;137:481–5.PubMedCrossRef Haga Y, Wada Y, Takeuchi H, Sameshima H, Kimura O, Furuya T. Estimation of surgical costs using a prediction scoring system estimation of physiologic ability and surgical stress. Arch Surg. 2002;137:481–5.PubMedCrossRef
17.
Zurück zum Zitat Haga Y, Wada Y, Takeuchi H, Kimura O, Furuya T, Sameshima H, et al. Estimation of physiologic ability and surgical stress (E-PASS) for a surgical audit in elective digestive surgery. Surgery. 2004;135:586–94.PubMedCrossRef Haga Y, Wada Y, Takeuchi H, Kimura O, Furuya T, Sameshima H, et al. Estimation of physiologic ability and surgical stress (E-PASS) for a surgical audit in elective digestive surgery. Surgery. 2004;135:586–94.PubMedCrossRef
18.
Zurück zum Zitat Oka Y, Nishijima J, Oku K, Azuma T, Inada K, Miyazaki S, et al. Usefulness of an estimation of physiologic ability and surgical stress (E-PASS) scoring system to predict the incidence of postoperative complications in gastrointestinal surgery. World J Surg. 2005;29:1029–33.PubMedCrossRef Oka Y, Nishijima J, Oku K, Azuma T, Inada K, Miyazaki S, et al. Usefulness of an estimation of physiologic ability and surgical stress (E-PASS) scoring system to predict the incidence of postoperative complications in gastrointestinal surgery. World J Surg. 2005;29:1029–33.PubMedCrossRef
19.
Zurück zum Zitat Banz VM, Studer P, Inderbitzin D, Candinas D. Validation of the estimation of physiologic ability and surgical stress (E-PASS) score in liver surgery. World J Surg. 2009;33:1259–65.PubMedCrossRef Banz VM, Studer P, Inderbitzin D, Candinas D. Validation of the estimation of physiologic ability and surgical stress (E-PASS) score in liver surgery. World J Surg. 2009;33:1259–65.PubMedCrossRef
20.
Zurück zum Zitat Hashimoto D, Takamori H, Sakamoto Y, Ikuta Y, Nakahara O, Furuhashi S, et al. Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci. 2010;17:132–8.PubMedCrossRef Hashimoto D, Takamori H, Sakamoto Y, Ikuta Y, Nakahara O, Furuhashi S, et al. Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci. 2010;17:132–8.PubMedCrossRef
21.
Zurück zum Zitat Haga Y, Ikejiri K, Wada Y, Takahashi T, Ikenaga M, Akiyama N, et al. A multicenter prospective study of surgical audit systems. Ann Surg. 2011;253:194–201.PubMedCrossRef Haga Y, Ikejiri K, Wada Y, Takahashi T, Ikenaga M, Akiyama N, et al. A multicenter prospective study of surgical audit systems. Ann Surg. 2011;253:194–201.PubMedCrossRef
22.
23.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.
24.
Zurück zum Zitat Owens WD, Felts JA, Spitznagel EL. ASA physiological status classifications: a study of consistency of ratings. Anesthesiology. 1978;49:239–43.PubMedCrossRef Owens WD, Felts JA, Spitznagel EL. ASA physiological status classifications: a study of consistency of ratings. Anesthesiology. 1978;49:239–43.PubMedCrossRef
25.
Zurück zum Zitat Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.PubMedCrossRef Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.PubMedCrossRef
26.
Zurück zum Zitat Doglietto GB, Gallitelli L, Pacelli F, Bellantone R, Malerba M, Sgadari A, et al. Protein-sparing therapy after major abdominal surgery: lack of clinical effects. Ann Surg. 1996;223:357–62.PubMedCrossRef Doglietto GB, Gallitelli L, Pacelli F, Bellantone R, Malerba M, Sgadari A, et al. Protein-sparing therapy after major abdominal surgery: lack of clinical effects. Ann Surg. 1996;223:357–62.PubMedCrossRef
27.
Zurück zum Zitat Haga Y, Beppu T, Doi K, Nozawa F, Mugita N, Ikei S, et al. Systemic inflammatory response syndrome (SIRS) and organ dysfunction following gastrointestinal surgery. Crit Care Med. 1997;25:1994–2000.PubMedCrossRef Haga Y, Beppu T, Doi K, Nozawa F, Mugita N, Ikei S, et al. Systemic inflammatory response syndrome (SIRS) and organ dysfunction following gastrointestinal surgery. Crit Care Med. 1997;25:1994–2000.PubMedCrossRef
28.
Zurück zum Zitat Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatrica. 2007;96:644–7.PubMedCrossRef Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatrica. 2007;96:644–7.PubMedCrossRef
29.
Zurück zum Zitat Hosmer DW, Lemeshow S. Summary measures of goodness-of-fit. In: Applied logistic regression. 2nd ed. New York: Wiley; 2000. p. 144–67. Hosmer DW, Lemeshow S. Summary measures of goodness-of-fit. In: Applied logistic regression. 2nd ed. New York: Wiley; 2000. p. 144–67.
30.
Zurück zum Zitat Katz D, Baptista J, Azen SP, Pike MC. Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics. 1978;34:469–74.CrossRef Katz D, Baptista J, Azen SP, Pike MC. Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics. 1978;34:469–74.CrossRef
31.
Zurück zum Zitat Hirose J, Mizuta H, Ide J, Nakamura E, Takada K. E-PASS for predicting postoperative risk with hip fracture: a multicenter study. Clin Orthop Relat Res. 2008;466:2833–41.PubMedCrossRef Hirose J, Mizuta H, Ide J, Nakamura E, Takada K. E-PASS for predicting postoperative risk with hip fracture: a multicenter study. Clin Orthop Relat Res. 2008;466:2833–41.PubMedCrossRef
32.
Zurück zum Zitat Tang T, Walsh SR, Fanshawe TR, Gillard JH, Sadat U, Varty K, et al. Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of immediate outcome after elective abdominal aortic aneurysm surgery. Am J Surg. 2007;194:176–82.PubMedCrossRef Tang T, Walsh SR, Fanshawe TR, Gillard JH, Sadat U, Varty K, et al. Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of immediate outcome after elective abdominal aortic aneurysm surgery. Am J Surg. 2007;194:176–82.PubMedCrossRef
33.
Zurück zum Zitat Yamashita S, Haga Y, Nemoto E, Nagai S, Ohta M. E-PASS (the estimation of physiologic ability and surgical stress) scoring system helps the prediction of postoperative morbidity and mortality in thoracic surgery. Eur Surg Res. 2004;36:249–55.PubMedCrossRef Yamashita S, Haga Y, Nemoto E, Nagai S, Ohta M. E-PASS (the estimation of physiologic ability and surgical stress) scoring system helps the prediction of postoperative morbidity and mortality in thoracic surgery. Eur Surg Res. 2004;36:249–55.PubMedCrossRef
34.
Zurück zum Zitat Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491–507.PubMedCrossRef Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491–507.PubMedCrossRef
35.
Zurück zum Zitat Macario A, Dexter F, Sypal J, Cosgriff N, Heniford BT. Operative time and other outcomes of the electrothermal bipolar vessel sealing system (LigaSure) versus other methods for surgical hemostasis: a meta-analysis. Surg Innov. 2008;15:284–91.PubMedCrossRef Macario A, Dexter F, Sypal J, Cosgriff N, Heniford BT. Operative time and other outcomes of the electrothermal bipolar vessel sealing system (LigaSure) versus other methods for surgical hemostasis: a meta-analysis. Surg Innov. 2008;15:284–91.PubMedCrossRef
36.
Zurück zum Zitat Kitamura K, Nishida S, Ichikawa D, Taniguchi H, Hagiwara A, Yamaguchi T, et al. No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br J Surg. 1999;86:119–22.PubMedCrossRef Kitamura K, Nishida S, Ichikawa D, Taniguchi H, Hagiwara A, Yamaguchi T, et al. No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br J Surg. 1999;86:119–22.PubMedCrossRef
Metadaten
Titel
Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in gastric carcinoma surgery
verfasst von
Yoshio Haga
Yasuo Wada
Hitoshi Takeuchi
Koji Ikejiri
Masakazu Ikenaga
Osamu Kimura
Publikationsdatum
01.01.2012
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 1/2012
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-011-0052-2

Weitere Artikel der Ausgabe 1/2012

Gastric Cancer 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.